Fine Particulate Matter Is Associated With Lower Executive Functioning in Middle-aged and Older Adults: Cardiometabolic Disease as a Mediator
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025
DOI: 10.1093/gerona/glaf104 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Sara E Grineski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sociology, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Particulate Matter, Executive Function, Environmental Exposure, Air Pollution. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
PM2.5 pollution is expected to worsen in many places due to climate change, as a result of hotter temperatures, less precipitation, and increases in wind speed. PM2.5 exposure has adverse effects on humans that may accelerate the aging process. Less is known about whether physical and mental health conditions mediate the relationship between PM2.5 exposure and aging-related cognitive and functional limitations.
Methods
Longitudinal data from the Midlife in the United States study (MIDUS 2: 2004–05; MIDUS 3: 2013–14) were used, with a sample of approximately 5 000 individuals aged 32–84. Based on individuals’ residential addresses at each wave, we identified census tract-level PM2.5 exposure as defined by 5-year annual averages. Missing data were handled using multiple imputation by chained equations. We examined cross-sectional and longitudinal associations between PM2.5 exposure and aging-related limitations (ie, executive functioning and functional limitations), and tested cardiometabolic disease and depressive symptoms as mediators.
Results
Higher PM2.5 exposure was associated with lower executive functioning cross-sectionally and longitudinally, but not with functional limitations. The cross-sectional association between PM2.5 and executive functioning was partially mediated by cardiometabolic disease, accounting for 8.1% of the estimate. Depressive symptoms were not a significant mediator.
Conclusions
Findings suggest the importance of considering the indirect ways in which climate change may affect health of middle-aged and older adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sociology, University of Utah, Salt Lake City, Utah, USA.
- School of Environment, Society and Sustainability, University of Utah, Salt Lake City, Utah, USA.
- Department of Family and Consumer Studies, University of Utah, Salt Lake City, Utah, USA.
- Department of Social Work and Social Administration, University of Hong Kong. Pok Fu Lam, Hong Kong.
ORCID-Profile: Sara E Grineski, Ethan Siu Leung Cheung
Förderung
- NIA NIH HHS
- NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Grineski, S. E., Cheung, E. S. L., Clark, A. S., & Curtis, D. S. (2025). Fine Particulate Matter Is Associated With Lower Executive Functioning in Middle-aged and Older Adults: Cardiometabolic Disease as a Mediator. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf104
Vancouver
Grineski SE, Cheung ESL, Clark AS, Curtis DS. Fine Particulate Matter Is Associated With Lower Executive Functioning in Middle-aged and Older Adults: Cardiometabolic Disease as a Mediator. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf104
BibTeX
@article{Grineski2025,
author = {Grineski, Sara E and Cheung, Ethan Siu Leung and Clark, Austin S and Curtis, David S},
title = {Fine Particulate Matter Is Associated With Lower Executive Functioning in Middle-aged and Older Adults: Cardiometabolic Disease as a Mediator},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
doi = {10.1093/gerona/glaf104}
}
EUVIMED